Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Clin Immunol. 2013 Jul 26;33(7):1223–1239. doi: 10.1007/s10875-013-9918-x

Table 1.

Summary of Jamaican cohort

Seronegative Control
S/N* Race Age
F1 Asian/Pacific 45
F2 Black 23
F3 Black 66
F4 Black 17
F5 Black 51
F6 Black 40
F7 Black 50
F8 Black 42
F9 Black 65
F10 Black 52
F11 Black 46
M1 Other 29
M2 Black 69
M3 Black 62
M4 Black 24
M5 Black 28
M6 Black 47
Asymptomatic carriers
S/N Race Age
F1 Black 57
F2 Black 19
F3 Black 23
F4 Black 40
F5 Black 62
F6 Black 43
F7 Black 40
F8 Black 42
F9 Black 40
F10 Black 46
F11 Black 49
M1 Black 73
M2 Black 45
M3 Black 30
M4 Black 19
M5 Black 13
M6 Black 63
ATL patients
S/N Race Age
F1 Black 48
F2 Black 49
F3 Black 53
F4 Black 68
F5 Black 49
F6 Black 68
F7 Black 41
F8 Black 27
F9 Black 20
F10 Black 51
F11 Black 41
M1 Black 30
M2 Black 57
M3 Black 22
M4 Other 25
M5 Other 46
M6 Other 75
HAM/TSP patients
S/N Race Age
F1 Black 41
F2 Black 23
F3 Black 49
F4 Black 42
F5 Black/White 51
F6 Black 19
F7 Black 47
F8 Black 64
F9 Black 49
F10 Black 63
M1 Black 16
M2 Black 22
M3 Black 75
M4 Black 46
M5 Black 57
M6 Black 31
M7 Black 57
*

F stands for female, M for male